# A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.

> **NCT04033939** · PHASE1 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 48 (actual)

## Conditions studied

- Anesthesia
- Sedation

## Interventions

- **DRUG:** HSK3486
- **DRUG:** Propofol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04033939
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-13
- **Primary completion:** 2014-11-11
- **Final completion:** 2015-05-04
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04033939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04033939, "A Study Evaluating the Safety, Pharmacodynamics and Pharmacokinetics of HSK3486 in Healthy Subjects.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04033939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*